Relationship of serum brain-derived neurotrophic factor level with other markers of disease severity in patients with atopic dermatitis
- 28 February 2007
- journal article
- research article
- Published by Elsevier in Clinical Immunology
- Vol. 122 (2) , 181-186
- https://doi.org/10.1016/j.clim.2006.10.011
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjectsJournal of Allergy and Clinical Immunology, 2005
- CD4+IL‐13+ cells in peripheral blood well correlates with the severity of atopic dermatitis in childrenAllergy, 2005
- Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation?The Journal of Experimental Medicine, 1999
- Soluble E‐selectin, other markers of inflammation and disease severity in children with atopic dermatitisBritish Journal of Dermatology, 1998
- Soluble E-selectin as a marker of disease activity in atopic dermatitis☆, ☆☆, ★, ★★Journal of Allergy and Clinical Immunology, 1997
- Clinical Validation and Guidelines for the SCORAD Index: Consensus Report of the European Task Force on Atopic DermatitisDermatology, 1997
- Characterisation of Neurotrophin Dimers and MonomersEuropean Journal of Biochemistry, 1994
- Serum soluble IL-2 receptor (sIL-2R) and eosinophil cationic protein (ECP) levels in atopic dermatitisJournal of Dermatological Science, 1994
- Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitisBritish Journal of Dermatology, 1992
- The nerve growth factor familyProgress in Growth Factor Research, 1990